P21(Cip1) Up-regulated During Histone Deacetylase Inhibitor-induced CD4(+) T-cell Anergy Selectively Associates with Mitogen-activated Protein Kinases

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2010 Jan 28

PMID 20102411

Citations 7

Authors

Ayse Selma Dagtas

Kathleen M Gilbert

Affiliations

Soon will be listed here.

Abstract

Histone deacetylase inhibitor n-butyrate induced proliferative unresponsiveness in antigen-stimulated murine CD4(+) T cells. T cells anergized by n-butyrate demonstrated reduced interleukin-2 (IL-2) secretion and decreased activating protein 1 (AP-1) activity upon restimulation. Mechanistic studies determined that the cyclin-dependent kinase (cdk) inhibitor p21(Cip1) was up-regulated in the anergic CD4(+) T cells. p21(Cip1) is known to inhibit the cell cycle through its interaction with cdk, proliferating cell nuclear antigen (PCNA) or c-Jun N-terminal kinase (JNK). p21(Cip1) did not preferentially associate with PCNA or cdk in anergic T helper type 1 (Th1) cells. Instead, among the three interaction partners, p21(Cip1) was found to interact with phospho-JNK and phospho-c-jun selectively in the anergic CD4(+) T cells. The activity of c-jun and downstream transcription factor AP-1 were suppressed in the anergic Th1 cells. In contrast, p21(Cip1) and the two phospho-proteins were never detected concurrently in the control CD4(+) T cells. The n-butyrate-induced p21(Cip1)-mediated inhibition of JNK and c-jun represents a novel potential mechanism by which proliferative unresponsiveness was maintained in CD4(+) T cells.

Citing Articles

Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.

He B, Chen Z, Nie Y, Luo M, Xu S, Yan J J Immunol Res. 2022; 2022:6588144.

PMID: 35733920 PMC: 9207021. DOI: 10.1155/2022/6588144.

Bone Morphogenetic Proteins Shape T Cells.

Kraj P Front Immunol. 2022; 13:865546.

PMID: 35418975 PMC: 8995768. DOI: 10.3389/fimmu.2022.865546.

Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production.

Daszkiewicz L, Vazquez-Mateo C, Rackov G, Ballesteros-Tato A, Weber K, Madrigal-Aviles A Sci Rep. 2015; 5:7691.

PMID: 25573673 PMC: 4287747. DOI: 10.1038/srep07691.

New roles for cyclin-dependent kinases in T cell biology: linking cell division and differentiation.

Wells A, Morawski P Nat Rev Immunol. 2014; 14(4):261-70.

PMID: 24603166 PMC: 10114933. DOI: 10.1038/nri3625.

Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest.

Zaher S, Coe D, Chai J, Larkin D, George A Immunology. 2012; 138(2):157-64.

PMID: 23121382 PMC: 3575768. DOI: 10.1111/imm.12026.

References

Li R, Waga S, Hannon G, Beach D, Stillman B . Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 1994; 371(6497):534-7. DOI: 10.1038/371534a0. View

Reddy P, Sun Y, Toubai T, Duran-Struuck R, Clouthier S, Weisiger E . Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest. 2008; 118(7):2562-73. PMC: 2430497. DOI: 10.1172/JCI34712. View

Gilbert K, Weigle W . Th1 cell anergy and blockade in G1a phase of the cell cycle. J Immunol. 1993; 151(3):1245-54. View

Li W, Whaley C, Mondino A, Mueller D . Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science. 1996; 271(5253):1272-6. DOI: 10.1126/science.271.5253.1272. View

Harper J, Adami G, Wei N, Keyomarsi K, Elledge S . The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993; 75(4):805-16. DOI: 10.1016/0092-8674(93)90499-g. View

Derijard B, Hibi M, Wu I, Barrett T, Su B, Deng T . JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994; 76(6):1025-37. DOI: 10.1016/0092-8674(94)90380-8. View

Rincon M . MAP-kinase signaling pathways in T cells. Curr Opin Immunol. 2001; 13(3):339-45. DOI: 10.1016/s0952-7915(00)00224-7. View

Kang S, Beverly B, Tran A, Brorson K, Schwartz R, Lenardo M . Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science. 1992; 257(5073):1134-8. DOI: 10.1126/science.257.5073.1134. View

Powell J, Lerner C, Schwartz R . Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol. 1999; 162(5):2775-84. View

10.

Arias C, Ballesteros-Tato A, Garcia M, Martin-Caballero J, Flores J, Martinez-A C . p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses. J Immunol. 2007; 178(4):2296-306. DOI: 10.4049/jimmunol.178.4.2296. View

11.

Patel R, Bartosch B, Blank J . p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression. J Cell Sci. 1998; 111 ( Pt 15):2247-55. DOI: 10.1242/jcs.111.15.2247. View

12.

Chen C, Wu Z, Karin M . Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science. 1998; 280(5371):1945-9. DOI: 10.1126/science.280.5371.1945. View

13.

Jackson S, DeLoose A, Gilbert K . The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors. Immunology. 2002; 106(4):486-95. PMC: 1782758. DOI: 10.1046/j.1365-2567.2002.01457.x. View

14.

Harper J, Elledge S, Keyomarsi K, Dynlacht B, Tsai L, Zhang P . Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995; 6(4):387-400. PMC: 301199. DOI: 10.1091/mbc.6.4.387. View

15.

Tao R, de Zoeten E, Ozkaynak E, Chen C, Wang L, Porrett P . Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med. 2007; 13(11):1299-307. DOI: 10.1038/nm1652. View

16.

Greenwald R, Boussiotis V, Lorsbach R, Abbas A, Sharpe A . CTLA-4 regulates induction of anergy in vivo. Immunity. 2001; 14(2):145-55. DOI: 10.1016/s1074-7613(01)00097-8. View

17.

Kurki P, Lotz M, Ogata K, Tan E . Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol. 1987; 138(12):4114-20. View

18.

Han Z, Boyle D, Chang L, Bennett B, Karin M, Yang L . c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest. 2001; 108(1):73-81. PMC: 209341. DOI: 10.1172/JCI12466. View

19.

Zhang H, Hannon G, Beach D . p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 1994; 8(15):1750-8. DOI: 10.1101/gad.8.15.1750. View

20.

Richon V, Sandhoff T, Rifkind R, Marks P . Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci U S A. 2000; 97(18):10014-9. PMC: 27656. DOI: 10.1073/pnas.180316197. View